Men diagnosed at this hospital trust can access the following services:

• Diagnostic Facilities:
• Multiparametric MRI
• Transperineal biopsy under local anaesthetic
• Transperineal biopsy under general anaesthetic
• Transrectal ultrasound (TRUS) biopsy
• Choline PET
• PSMA (prostate-specific membrane antigen) PET scan
• Whole body MRI
• Isotope bone scan

• Treatment Facilities:
• External beam radiotherapy (EBRT)
• Stereotactic body radiation therapy (SBRT)
• Chemotherapy
• Joint specialist MDT clinic

• Support Service Facilities:
• Clinical Nurse Specialist (CNS) in all clinics
• Prostate cancer-specific CNSs
• Advanced PCa CNS
• Urology CNS
• Sexual function services
• Specialist continence services
• Psychological counselling
• Onco-geriatric service

	Diagnosing Trust	Specialist MDT
No. of Cancer Registry records	348	348
Performance Status recorded	4%	4%
PSA completed	87%	87%
Gleason Score completed	N/A	N/A
TNM completed	10%	10%
Stage variable assigned	67%	67%

	Specialist MDT	National
No. of men with disease status determined	232	23477
Percentage of men diagnosed with metastatic disease	11%	17%
No. of men diagnosed with M1 (metastases)	25	N/A

These indicators could not be reported this year for England as we were unable to assign a patient to a particular risk group due to the unavailability of information on Gleason score in the Rapid Cancer Registration Dataset

	Treatment Centre
No. of men who received radical radiotherapy ()	164
Adjusted percentage of men experiencing at least one GI complication (%)